Bioequivalence is a term used in biotechnology to describe the similarity between two pharmaceutical products. It is used to assess the interchangeability of two products, such as generic and brand-name drugs, and to ensure that they have the same therapeutic effect. Bioequivalence studies are conducted to compare the pharmacokinetic properties of two products, such as their absorption, distribution, metabolism, and excretion. The results of these studies are used to determine whether the two products are therapeutically equivalent and can be used interchangeably. The bioequivalence market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for generic drugs, as well as the need for regulatory compliance. Companies in this market provide services such as bioequivalence studies, pharmacokinetic analysis, and regulatory consulting. Some companies in the bioequivalence market include Parexel, Covance, Quintiles, and PPD. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
